Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flucloxacillin pharmacokinetic model in adults with impaired renal function
NL-OMON41120Active, not recruiting
- Sponsor
- Atrium Medisch Centrum Parkstad
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of flucloxacillin in bacterial disease, sponsored by Atrium Medisch Centrum Parkstad. Primary endpoint: Development of a pharmacokinetic model for flucloxacillin dosing. Started Jan 2015; status: active, not recruiting.
02
Drugs
flucloxacillin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON41120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41120.